A carregar...
Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability
Results of a study, published in this issue of The Oncologist, comparing capecitabine and oxaliplatin plus bevacizumab with the same regimen for only six cycles followed by bevacizumab monotherapy in metastatic colorectal cancer patients are examined.
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3267828/ https://ncbi.nlm.nih.gov/pubmed/22234629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0358 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|